Cargando…
Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications
Because of the high research and development cost of new drugs, the long development process of new drugs, and the high failure rate at later stages, combining past drugs has gradually become a more economical and attractive alternative. However, the ensuing problem of drug–drug interactions (DDIs)...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456269/ https://www.ncbi.nlm.nih.gov/pubmed/37623842 http://dx.doi.org/10.3390/metabo13080897 |
_version_ | 1785096655891070976 |
---|---|
author | Sun, Lei Mi, Kun Hou, Yixuan Hui, Tianyi Zhang, Lan Tao, Yanfei Liu, Zhenli Huang, Lingli |
author_facet | Sun, Lei Mi, Kun Hou, Yixuan Hui, Tianyi Zhang, Lan Tao, Yanfei Liu, Zhenli Huang, Lingli |
author_sort | Sun, Lei |
collection | PubMed |
description | Because of the high research and development cost of new drugs, the long development process of new drugs, and the high failure rate at later stages, combining past drugs has gradually become a more economical and attractive alternative. However, the ensuing problem of drug–drug interactions (DDIs) urgently need to be solved, and combination has attracted a lot of attention from pharmaceutical researchers. At present, DDI is often evaluated and investigated from two perspectives: pharmacodynamics and pharmacokinetics. However, in some special cases, DDI cannot be accurately evaluated from a single perspective. Therefore, this review describes and compares the current DDI evaluation methods based on two aspects: pharmacokinetic interaction and pharmacodynamic interaction. The methods summarized in this paper mainly include probe drug cocktail methods, liver microsome and hepatocyte models, static models, physiologically based pharmacokinetic models, machine learning models, in vivo comparative efficacy studies, and in vitro static and dynamic tests. This review aims to serve as a useful guide for interested researchers to promote more scientific accuracy and clinical practical use of DDI studies. |
format | Online Article Text |
id | pubmed-10456269 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104562692023-08-26 Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications Sun, Lei Mi, Kun Hou, Yixuan Hui, Tianyi Zhang, Lan Tao, Yanfei Liu, Zhenli Huang, Lingli Metabolites Review Because of the high research and development cost of new drugs, the long development process of new drugs, and the high failure rate at later stages, combining past drugs has gradually become a more economical and attractive alternative. However, the ensuing problem of drug–drug interactions (DDIs) urgently need to be solved, and combination has attracted a lot of attention from pharmaceutical researchers. At present, DDI is often evaluated and investigated from two perspectives: pharmacodynamics and pharmacokinetics. However, in some special cases, DDI cannot be accurately evaluated from a single perspective. Therefore, this review describes and compares the current DDI evaluation methods based on two aspects: pharmacokinetic interaction and pharmacodynamic interaction. The methods summarized in this paper mainly include probe drug cocktail methods, liver microsome and hepatocyte models, static models, physiologically based pharmacokinetic models, machine learning models, in vivo comparative efficacy studies, and in vitro static and dynamic tests. This review aims to serve as a useful guide for interested researchers to promote more scientific accuracy and clinical practical use of DDI studies. MDPI 2023-07-29 /pmc/articles/PMC10456269/ /pubmed/37623842 http://dx.doi.org/10.3390/metabo13080897 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sun, Lei Mi, Kun Hou, Yixuan Hui, Tianyi Zhang, Lan Tao, Yanfei Liu, Zhenli Huang, Lingli Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications |
title | Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications |
title_full | Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications |
title_fullStr | Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications |
title_full_unstemmed | Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications |
title_short | Pharmacokinetic and Pharmacodynamic Drug–Drug Interactions: Research Methods and Applications |
title_sort | pharmacokinetic and pharmacodynamic drug–drug interactions: research methods and applications |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456269/ https://www.ncbi.nlm.nih.gov/pubmed/37623842 http://dx.doi.org/10.3390/metabo13080897 |
work_keys_str_mv | AT sunlei pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications AT mikun pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications AT houyixuan pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications AT huitianyi pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications AT zhanglan pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications AT taoyanfei pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications AT liuzhenli pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications AT huanglingli pharmacokineticandpharmacodynamicdrugdruginteractionsresearchmethodsandapplications |